Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study.
作者信息
Thorsteinsdottir Sigrun, Dickman Paul W, Landgren Ola, Blimark Cecilie, Hultcrantz Malin, Turesson Ingemar, Björkholm Magnus, Kristinsson Sigurdur Y
机构信息
Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
出版信息
Haematologica. 2018 Sep;103(9):e412-e415. doi: 10.3324/haematol.2017.183475. Epub 2018 Mar 22.
Abstract
摘要
相似文献
1
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study.
Haematologica. 2018 Sep;103(9):e412-e415. doi: 10.3324/haematol.2017.183475. Epub 2018 Mar 22.
2
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
Br J Haematol. 2013 Oct;163(1):40-6. doi: 10.1111/bjh.12465. Epub 2013 Jul 27.
3
Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).
Leuk Lymphoma. 2015;56(9):2660-7. doi: 10.3109/10428194.2014.1003060. Epub 2015 Mar 11.
4
Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014.
Leukemia. 2018 Sep;32(9):2054-2057. doi: 10.1038/s41375-018-0057-5. Epub 2018 Feb 22.
5
Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.
Leuk Lymphoma. 2014 May;55(5):1083-9. doi: 10.3109/10428194.2013.827188. Epub 2013 Sep 3.
6
Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups.
Leuk Lymphoma. 2014 Dec;55(12):2850-7. doi: 10.3109/10428194.2014.897700. Epub 2014 May 9.
7
Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades.
Leuk Lymphoma. 2018 Jan;59(1):49-58. doi: 10.1080/10428194.2017.1335398. Epub 2017 Jun 9.
8
Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982-2017.
Br J Haematol. 2020 Nov;191(3):418-425. doi: 10.1111/bjh.16674. Epub 2020 May 5.
9
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
BMC Cancer. 2015 Nov 5;15:850. doi: 10.1186/s12885-015-1857-x.
10
Real-world epidemiology, treatment patterns and survival of multiple myeloma patients in a large nationwide health plan.
Leuk Res. 2019 Oct;85:106219. doi: 10.1016/j.leukres.2019.106219. Epub 2019 Aug 23.
引用本文的文献
1
Genetic and Epigenetic Aberrations of in Newly Diagnosed and Relapsed Multiple Myeloma as Well as Related Neoplasms.
Curr Issues Mol Biol. 2025 Apr 1;47(4):244. doi: 10.3390/cimb47040244.
2
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience.
Blood Neoplasia. 2025 Apr 16;2(3):100103. doi: 10.1016/j.bneo.2025.100103. eCollection 2025 Aug.
3
Temporal patterns in US population-based patient survival among adults treated with chemotherapy and/or immunotherapy for multiple myeloma, 2000-2020.
Br J Haematol. 2025 Jun 10. doi: 10.1111/bjh.20192.
4
The role of IL-17-related signaling in myelomagenesis, disease prognosis/progression, and therapeutic approach-a scoping review.
Clin Exp Med. 2025 Jun 9;25(1):194. doi: 10.1007/s10238-025-01728-6.
5
MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study.
Front Pharmacol. 2025 Apr 4;16:1465814. doi: 10.3389/fphar.2025.1465814. eCollection 2025.
6
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: The EMMY Cohort From 2017 to 2020.
Cancer Med. 2025 Mar;14(6):e70619. doi: 10.1002/cam4.70619.
7
Evolution of Survival in Patients with Multiple Myeloma over Two Decades: A Real-World Experience from a Medium-Level Hospital.
Cancers (Basel). 2025 Feb 25;17(5):793. doi: 10.3390/cancers17050793.
8
The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone.
Hematol Rep. 2024 Sep 30;16(4):593-602. doi: 10.3390/hematolrep16040058.
9
Deep hematologic response to RD treatment in patients with multiple myeloma is associated with overexpression of IL-17R in CD138+ plasma cells.
Sci Rep. 2024 Oct 9;14(1):23559. doi: 10.1038/s41598-024-74558-3.
10
Multiple myeloma survival in New South Wales, Australia, by treatment era to 2020.
Cancer Biol Med. 2024 Jul 11;21(8):703-11. doi: 10.20892/j.issn.2095-3941.2024.0177.
本文引用的文献
1
Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
Haematologica. 2018 Mar;103(3):506-513. doi: 10.3324/haematol.2017.178103. Epub 2017 Dec 7.
2
Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validity.
Leuk Lymphoma. 2016 Dec;57(12):2827-2832. doi: 10.3109/10428194.2016.1170828. Epub 2016 Apr 22.
3
Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma.
Am J Hematol. 2016 Jan;91(1):101-8. doi: 10.1002/ajh.24129.
4
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Lancet Oncol. 2014 Aug;15(9):931-42. doi: 10.1016/S1470-2045(14)70282-7. Epub 2014 Jul 13.
5
Where we were, where we are, where we are going: progress in multiple myeloma.
Am Soc Clin Oncol Educ Book. 2014:199-203. doi: 10.14694/EdBook_AM.2014.34.199.
6
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.
J Clin Oncol. 2014 Feb 20;32(6):587-600. doi: 10.1200/JCO.2013.48.7934. Epub 2014 Jan 13.
7
Improved long-term survival in multiple myeloma up to the age of 80 years.
Leukemia. 2014 Jun;28(6):1346-8. doi: 10.1038/leu.2014.23. Epub 2014 Jan 14.
8
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
Leukemia. 2014 May;28(5):1122-8. doi: 10.1038/leu.2013.313. Epub 2013 Oct 25.
9
Can multiple myeloma become a curable disease?
Haematologica. 2011 Sep;96(9):1246-8. doi: 10.3324/haematol.2011.051169.
10
Multiple myeloma.
N Engl J Med. 2011 Mar 17;364(11):1046-60. doi: 10.1056/NEJMra1011442.
Zotero 插件